In early-morning trading Tuesday, the biotech giant climbed $20.86 -- or 5.8% -- to $379 a share after the company reported second-quarter earnings that easily beat Wall Street estimates.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,